EGFR在良性卵巢肿瘤组织中的阳性表达率分别为40.0%，在卵巢癌组织中的阳性表达率为80.0%；
The positive rate of EGFR was 40.0% in ovarian benign tumor, and was 80.0% in ovarian cancer.
卵巢癌：卵巢的恶性肿瘤。
方法用ELISA法分别检测卵巢良性肿瘤和卵巢癌患者术前及化疗前血清CA125和TPS水平。
Methods Serum levers of CA125 and TPS in patients with benign ovary tumor and patients with ovary cancer were measured by ELISA.
卵巢癌仍然是妇科恶性肿瘤疾病的主要死亡原因，并且大部分卵巢恶性肿瘤来自于卵巢表面上皮细胞。
Ovarian carcinoma continues to be the leading cause of death in malignant cancer of gynecology, which is almost derived from the ovarian surface epithelium.
其中浆液性卵巢癌是卵巢上皮性癌中最常见的组织学类型，占卵巢恶性肿瘤的50%。
One of serous ovarian cancer is epithelial ovarian cancer the most common histological type, accounting for 50% of malignant ovarian tumors.
方法应用免疫组织化学法(SP方法)，检测15例正常卵巢组织，15例卵巢良性肿瘤组织及60例卵巢癌组织中egfr的表达情况。
Methods Immunohistochemistrical SP method was used to detect the expression of EGFR in 15 cases of normal ovarian tissue and 15 cases of benign ovarian tumor and 60 cases ovarian cancer.
结果卵巢癌组患者血清TSGF水平明显高于卵巢良性肿瘤组；
Results The levels of TSGF in the patients with ovarian cancer are higher than those of TSGF in the patients with benign ovarian tumors;
结论？肿瘤组织的血管生成在卵巢癌的浸润性生长及转移方面起着重要作用，MVD可作为判断恶性卵巢肿瘤预后的一项重要指标。
Conclusions? Tumor angiogenesis plays an important role in tumor invasion and metastasis. MVD may serve as a significant prognostic indicator in EOC.
卵巢癌是妇科恶性肿瘤中致死率最高的肿瘤，目前通常用于判断卵巢癌预后的指标有FIGO分期、肿瘤分级、肿瘤组织学类型等。
Ovarian carcinoma is the most lethal gynecologic malignancy. Nowadays, conventional prognostic markers in ovarian cancer have included FIGO stage, tumor grade, histology et al.
结论：KLK6,10基因在卵巢癌组织表达明显增强，有望成为卵巢癌的肿瘤标志物。
Conclusion: the expression levels of KLK6, 10 gene were highly increased in ovarian cancer tis-sues, they may become new tumor markers for ovarian cancer.
结论：KLK6,10基因在卵巢癌组织表达明显增强，有望成为卵巢癌的肿瘤标志物。
Conclusion: the expression levels of KLK6, 10 gene were highly increased in ovarian cancer tis-sues, they may become new tumor markers for ovarian cancer.
应用推荐